US Patent Issued to KM Biologics on May 6 for "Vaccine for preventing or treating congenital infection with cytomegalovirus" (Japanese Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,560, issued on May 6, was assigned to KM Biologics Co. Ltd. (Kumamoto, Japan).

"Vaccine for preventing or treating congenital infection with cytomegalovirus" was invented by Masaharu Torikai (Kumamoto, Japan), Hiroaki Mori (Kumamoto, Japan), Tomohiro Nishimura (Kumamoto, Japan), Takahiro Katayama (Kanagawa, Japan), Kohsuke Hazeyama (Kumamoto, Japan), Miyuki Matsumoto (Kumamoto, Japan), Hiroyuki Shimizu (Saitama, Japan) and Naoki Inoue (Gifu, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An object of the present invention is to provide an effective vaccine capable of preventing and treating congenital infection with CMV. The vaccine for preven...